Developments during 2021 related to Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA) regulatory and enforcement activities — including the FDA’s activities related to the COVID-19 public health emergency — are likely to reverberate throughout 2022.
This white paper from Thompson FDA presents our list of the 10 most important FDA and DEA developments of 2021, and some predictions of what to expect during 2022.
By downloading this free resource, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.